Intra-Cellular Therapies Inc. buy BiotechBee
Start price
23.09.22
/
60%
€44.49
Target price
31.07.25
€80.00
Performance (%)
28.12%
End price
05.05.23
€57.00
Summary
This prediction ended on 05.05.23 with a price of €57.00. The prediction had a final performance of 28.12%. BiotechBee has a follow-up prediction for Intra-Cellular Therapies Inc. where he still thinks Intra-Cellular Therapies Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intra-Cellular Therapies Inc. | -4.698% | -4.698% | 33.459% |
iShares Core DAX® | -3.935% | -3.998% | 11.192% |
iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% |
iShares Nikkei 225® | -4.513% | -8.017% | 5.961% |
iShares S&P 500 | -2.607% | -4.265% | 21.865% |
According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy mit Kursziel 80,0
In the thread Trading Intra-Cellular Therapies Inc.
Buy beendet
Current prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.40
19.02.24
19.02.24
€85.00
30.09.25
30.09.25
0.86%
20:21
20:21
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€58.60
24.06.23
24.06.23
€90.00
30.06.26
30.06.26
18.43%
19.02.24
19.02.24
Could be very worthwhile Investment >20% year